LSE Equity Snapshot

OXB Weekly Equity Report

Oxford Biomedica plc

Interactive chart JSON snapshot
Latest Close 600.0 GBP 12 Jun 2026
1W Return -4.8% latest completed week
4W Return -2.9% short-term follow-through
12W Return -2.8% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary ‘plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The …

Snapshot

What the weekly tape is saying

OXB closed the latest completed week at 600.0 GBP. The 4-week return is -2.9% and the 12-week return is -2.8%. Trend Signal is inactive, Market Dynamics is -0.25. Setup signature: Risk-first tape with a 29/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -9.4%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 34 Persistence of active Trend Signal over the last year and current streak.
Momentum 41 Blend of 4-week and 12-week follow-through.
Dynamics 51 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 10 Relative leadership and short-term RS change.
Volume 39 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
662.3 GBP
Vs Trend Line
-9.4%
Fair Value
407.2 GBP
Vs Fair Value
47.4%
52W High
962.0 GBP
52W Low
305.5 GBP
Drawdown
-37.6%
Range Position
44.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -4.8%
4W -2.9%
12W -2.8%
26W -4.2%
52W 85.2%

Trend read

Active Streak
0 weeks
52W Active Weeks
32
52W Active Breadth
61.5%
Sector Scope
GB Healthcare
Sector Rank
59 of 78
Sector Percentile
24.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.25
4W MD Change
72.3%
Relative Strength
-5.54
4W RS Change
-297.3%
Expectation
Negative
Probability
43.19%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.3M
13W Average
1.4M
52W Average
1.4M
Vs 13W
0.9x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.8%
52W Volatility
7.4%
Upside Weeks
27
Downside Weeks
24
Downside Breadth
46.2%
Avg Gain / Loss
6.9% / -4.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
LSE
Country
GB
Sector
Healthcare
Industry
Biotechnology
Currency
GBP
Market Cap
759.4M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 600.0 GBP -4.8% 662.3 GBP 407.2 GBP -0.25 -5.54 1.3M Off
5 Jun 2026 630.0 GBP 0.3% 662.4 GBP 406.3 GBP -0.43 0.84 2.6M Off
29 May 2026 628.0 GBP 1.6% 662.1 GBP 405.2 GBP -0.72 0.82 1.3M Off
22 May 2026 618.0 GBP 0.0% 663.0 GBP 404.2 GBP -0.84 -0.58 1.2M Off
15 May 2026 618.0 GBP -4.8% 662.7 GBP 403.1 GBP -0.92 2.81 1.1M Off
8 May 2026 649.0 GBP 9.4% 661.7 GBP 402.0 GBP -0.98 8.48 1.1M Off
1 May 2026 593.0 GBP -3.3% 661.5 GBP 400.4 GBP -1.12 -1.20 1.4M Off
24 Apr 2026 613.0 GBP -4.4% 662.3 GBP 399.3 GBP -1.19 2.77 1.4M Off
17 Apr 2026 641.0 GBP 13.3% 660.1 GBP 398.1 GBP -1.20 5.38 1.0M Off
10 Apr 2026 566.0 GBP 1.1% 658.4 GBP 396.9 GBP -1.16 -5.59 859.6K Off
3 Apr 2026 560.0 GBP -0.2% 658.8 GBP 396.1 GBP -1.06 -4.53 863.9K Off
27 Mar 2026 561.0 GBP -9.1% 659.9 GBP 395.2 GBP -0.92 0.86 2.0M Off
20 Mar 2026 617.0 GBP -2.1% 660.0 GBP 394.4 GBP -0.61 12.27 1.8M Off
13 Mar 2026 630.0 GBP 1.0% 657.5 GBP 393.2 GBP -0.28 11.85 869.8K On